Immunotherapy approaches for the treatment of diffuse midline gliomas.

Saved in:
Bibliographic Details
Title: Immunotherapy approaches for the treatment of diffuse midline gliomas.
Authors: Bernstock JD; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Hoffman SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Cancer Center, Boston, MA, USA., Kappel AD; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Valdes PA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Essayed W; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Klinger NV; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Kang KD; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA., Totsch SK; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA., Olsen HE; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Schlappi CW; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Cancer Center, Boston, MA, USA., Filipski K; Neurological Institute (Edinger Institute), University Hospital, Frankfurt Am Main, Germany.; German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DFKZ), Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt, Germany.; University Cancer Center (UCT), Frankfurt, Germany., Gessler FA; Department of Neurosurgery, University Medicine Rostock, Rostock, Germany., Baird L; Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Filbin MG; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Cancer Center, Boston, MA, USA., Hashizume R; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Becher OJ; Department of Pediatrics, Division of Pediatric Hematology-Oncology, the Mount Sinai Hospital, NY, NY, USA., Friedman GK; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Source: Oncoimmunology [Oncoimmunology] 2022 Sep 26; Vol. 11 (1), pp. 2124058. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2022.2124058